top of page

Spero Biopharma

Prevention and Treatment of Alzheimer's Disease

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Company Founded Year
Company Number of Employees
Spero Biopharma
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)

Spero Biopharma is the developer of Ladostigil, a drug designed to treat mild cognitive impairment before it progresses to Alzheimer's disease.

bottom of page